SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
DBX2
|
ENSG00000185610.6 | developing brain homeobox 2 |
HLX
|
ENSG00000136630.11 | H2.0 like homeobox |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HLX | hg19_v2_chr1_+_221051699_221051699 | 0.60 | 4.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_54466179 | 2.98 |
ENST00000270458.2
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8 |
chr6_-_25874440 | 2.25 |
ENST00000361703.6
ENST00000397060.4 |
SLC17A3
|
solute carrier family 17 (organic anion transporter), member 3 |
chr17_+_67498538 | 1.62 |
ENST00000589647.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
chr12_+_20963632 | 1.56 |
ENST00000540853.1
ENST00000261196.2 |
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr10_+_91152303 | 1.54 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr22_-_29107919 | 1.41 |
ENST00000434810.1
ENST00000456369.1 |
CHEK2
|
checkpoint kinase 2 |
chr12_+_20963647 | 1.37 |
ENST00000381545.3
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr10_+_5135981 | 1.31 |
ENST00000380554.3
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
chr19_-_58864848 | 1.31 |
ENST00000263100.3
|
A1BG
|
alpha-1-B glycoprotein |
chr4_+_155484155 | 1.20 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr2_-_225811747 | 1.19 |
ENST00000409592.3
|
DOCK10
|
dedicator of cytokinesis 10 |
chr10_+_70847852 | 1.16 |
ENST00000242465.3
|
SRGN
|
serglycin |
chr17_-_64225508 | 1.15 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr20_-_33735070 | 1.15 |
ENST00000374491.3
ENST00000542871.1 ENST00000374492.3 |
EDEM2
|
ER degradation enhancer, mannosidase alpha-like 2 |
chr11_-_559377 | 1.10 |
ENST00000486629.1
|
C11orf35
|
chromosome 11 open reading frame 35 |
chr8_-_145754428 | 1.09 |
ENST00000527462.1
ENST00000313465.5 ENST00000524821.1 |
C8orf82
|
chromosome 8 open reading frame 82 |
chr5_+_175288631 | 1.01 |
ENST00000509837.1
|
CPLX2
|
complexin 2 |
chr7_-_16844611 | 0.96 |
ENST00000401412.1
ENST00000419304.2 |
AGR2
|
anterior gradient 2 |
chr4_+_155484103 | 0.96 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr10_+_5090940 | 0.93 |
ENST00000602997.1
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
chr19_+_50016610 | 0.93 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr6_+_127439749 | 0.88 |
ENST00000356698.4
|
RSPO3
|
R-spondin 3 |
chr2_+_101591314 | 0.82 |
ENST00000450763.1
|
NPAS2
|
neuronal PAS domain protein 2 |
chr8_-_124749609 | 0.82 |
ENST00000262219.6
ENST00000419625.1 |
ANXA13
|
annexin A13 |
chr21_+_33671264 | 0.78 |
ENST00000339944.4
|
MRAP
|
melanocortin 2 receptor accessory protein |
chr17_-_38821373 | 0.78 |
ENST00000394052.3
|
KRT222
|
keratin 222 |
chr8_-_124741451 | 0.77 |
ENST00000520519.1
|
ANXA13
|
annexin A13 |
chr4_-_89442940 | 0.76 |
ENST00000527353.1
|
PIGY
|
phosphatidylinositol glycan anchor biosynthesis, class Y |
chr19_+_13842559 | 0.75 |
ENST00000586600.1
|
CCDC130
|
coiled-coil domain containing 130 |
chr8_+_62200509 | 0.75 |
ENST00000519846.1
ENST00000518592.1 ENST00000325897.4 |
CLVS1
|
clavesin 1 |
chr12_-_10978957 | 0.75 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr1_+_66820058 | 0.74 |
ENST00000480109.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr8_+_42396274 | 0.73 |
ENST00000438528.3
|
SMIM19
|
small integral membrane protein 19 |
chr3_-_114790179 | 0.72 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr19_-_3557570 | 0.71 |
ENST00000355415.2
|
MFSD12
|
major facilitator superfamily domain containing 12 |
chr9_-_21482312 | 0.71 |
ENST00000448696.3
|
IFNE
|
interferon, epsilon |
chr2_+_103035102 | 0.71 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr12_+_20968608 | 0.70 |
ENST00000381541.3
ENST00000540229.1 ENST00000553473.1 ENST00000554957.1 |
LST3
SLCO1B3
SLCO1B7
|
Putative solute carrier organic anion transporter family member 1B7; Uncharacterized protein solute carrier organic anion transporter family, member 1B3 solute carrier organic anion transporter family, member 1B7 (non-functional) |
chr1_-_45988542 | 0.67 |
ENST00000424390.1
|
PRDX1
|
peroxiredoxin 1 |
chr16_-_28937027 | 0.67 |
ENST00000358201.4
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr14_-_54425475 | 0.67 |
ENST00000559642.1
|
BMP4
|
bone morphogenetic protein 4 |
chr11_+_101918153 | 0.66 |
ENST00000434758.2
ENST00000526781.1 ENST00000534360.1 |
C11orf70
|
chromosome 11 open reading frame 70 |
chr13_+_78315295 | 0.65 |
ENST00000351546.3
|
SLAIN1
|
SLAIN motif family, member 1 |
chr9_+_34652164 | 0.64 |
ENST00000441545.2
ENST00000553620.1 |
IL11RA
|
interleukin 11 receptor, alpha |
chr19_-_36304201 | 0.63 |
ENST00000301175.3
|
PRODH2
|
proline dehydrogenase (oxidase) 2 |
chrX_-_106243451 | 0.63 |
ENST00000355610.4
ENST00000535534.1 |
MORC4
|
MORC family CW-type zinc finger 4 |
chr15_-_72563585 | 0.63 |
ENST00000287196.9
ENST00000260376.7 |
PARP6
|
poly (ADP-ribose) polymerase family, member 6 |
chr17_-_8113542 | 0.63 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr19_+_50016411 | 0.62 |
ENST00000426395.3
ENST00000600273.1 ENST00000599988.1 |
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr22_-_50970919 | 0.60 |
ENST00000329363.4
ENST00000437588.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr12_+_12510352 | 0.59 |
ENST00000298571.6
|
LOH12CR1
|
loss of heterozygosity, 12, chromosomal region 1 |
chr2_-_165424973 | 0.59 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
chr6_-_24358264 | 0.58 |
ENST00000378454.3
|
DCDC2
|
doublecortin domain containing 2 |
chr14_-_92247032 | 0.58 |
ENST00000556661.1
ENST00000553676.1 ENST00000554560.1 |
CATSPERB
|
catsper channel auxiliary subunit beta |
chr7_+_99195677 | 0.57 |
ENST00000431679.1
|
GS1-259H13.2
|
GS1-259H13.2 |
chr22_+_30821732 | 0.57 |
ENST00000355143.4
|
MTFP1
|
mitochondrial fission process 1 |
chr20_+_3767547 | 0.57 |
ENST00000344256.6
ENST00000379598.5 |
CDC25B
|
cell division cycle 25B |
chr14_-_54423529 | 0.54 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
chr9_+_67977438 | 0.54 |
ENST00000456982.1
|
RP11-195B21.3
|
Protein LOC644249 |
chr2_-_58468437 | 0.54 |
ENST00000403676.1
ENST00000427708.2 ENST00000403295.3 ENST00000446381.1 ENST00000417361.1 ENST00000233741.4 ENST00000402135.3 ENST00000540646.1 ENST00000449070.1 |
FANCL
|
Fanconi anemia, complementation group L |
chr4_+_113568207 | 0.53 |
ENST00000511529.1
|
LARP7
|
La ribonucleoprotein domain family, member 7 |
chr15_+_50474385 | 0.53 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr2_-_179343226 | 0.53 |
ENST00000434643.2
|
FKBP7
|
FK506 binding protein 7 |
chr7_-_35013217 | 0.53 |
ENST00000446375.1
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
chr8_+_98900132 | 0.52 |
ENST00000520016.1
|
MATN2
|
matrilin 2 |
chrX_-_106243294 | 0.52 |
ENST00000255495.7
|
MORC4
|
MORC family CW-type zinc finger 4 |
chr17_+_22022437 | 0.51 |
ENST00000540040.1
|
MTRNR2L1
|
MT-RNR2-like 1 |
chr4_-_48116540 | 0.51 |
ENST00000506073.1
|
TXK
|
TXK tyrosine kinase |
chr10_-_22292675 | 0.51 |
ENST00000376946.1
|
DNAJC1
|
DnaJ (Hsp40) homolog, subfamily C, member 1 |
chr1_+_196788887 | 0.50 |
ENST00000320493.5
ENST00000367424.4 ENST00000367421.3 |
CFHR1
CFHR2
|
complement factor H-related 1 complement factor H-related 2 |
chr15_+_69857515 | 0.50 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
chr6_+_26104104 | 0.50 |
ENST00000377803.2
|
HIST1H4C
|
histone cluster 1, H4c |
chr7_-_107883678 | 0.50 |
ENST00000417701.1
|
NRCAM
|
neuronal cell adhesion molecule |
chr17_+_79849872 | 0.49 |
ENST00000584197.1
ENST00000583839.1 |
ANAPC11
|
anaphase promoting complex subunit 11 |
chr1_-_89591749 | 0.49 |
ENST00000370466.3
|
GBP2
|
guanylate binding protein 2, interferon-inducible |
chr2_+_105050794 | 0.49 |
ENST00000429464.1
ENST00000414442.1 ENST00000447380.1 |
AC013402.2
|
long intergenic non-protein coding RNA 1102 |
chr15_+_75639372 | 0.48 |
ENST00000566313.1
ENST00000568059.1 ENST00000568881.1 |
NEIL1
|
nei endonuclease VIII-like 1 (E. coli) |
chrX_-_110655306 | 0.47 |
ENST00000371993.2
|
DCX
|
doublecortin |
chr10_+_35484793 | 0.46 |
ENST00000488741.1
ENST00000474931.1 ENST00000468236.1 ENST00000344351.5 ENST00000490511.1 |
CREM
|
cAMP responsive element modulator |
chr7_-_37024665 | 0.46 |
ENST00000396040.2
|
ELMO1
|
engulfment and cell motility 1 |
chr4_+_71019903 | 0.46 |
ENST00000344526.5
|
C4orf40
|
chromosome 4 open reading frame 40 |
chr8_+_31497271 | 0.45 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
chr5_+_157158205 | 0.45 |
ENST00000231198.7
|
THG1L
|
tRNA-histidine guanylyltransferase 1-like (S. cerevisiae) |
chr8_-_101157680 | 0.45 |
ENST00000428847.2
|
FBXO43
|
F-box protein 43 |
chr11_-_10530723 | 0.44 |
ENST00000536684.1
|
MTRNR2L8
|
MT-RNR2-like 8 |
chr2_+_143635067 | 0.44 |
ENST00000264170.4
|
KYNU
|
kynureninase |
chr10_-_22292613 | 0.44 |
ENST00000376980.3
|
DNAJC1
|
DnaJ (Hsp40) homolog, subfamily C, member 1 |
chr1_+_196743912 | 0.44 |
ENST00000367425.4
|
CFHR3
|
complement factor H-related 3 |
chr2_+_135596180 | 0.44 |
ENST00000283054.4
ENST00000392928.1 |
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr3_-_148939598 | 0.44 |
ENST00000455472.3
|
CP
|
ceruloplasmin (ferroxidase) |
chr8_-_27695552 | 0.43 |
ENST00000522944.1
ENST00000301905.4 |
PBK
|
PDZ binding kinase |
chr13_-_110438914 | 0.43 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr1_-_150738261 | 0.43 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr10_+_96698406 | 0.43 |
ENST00000260682.6
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
chr4_+_41540160 | 0.41 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr1_-_204183071 | 0.41 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
chr9_-_39239171 | 0.40 |
ENST00000358144.2
|
CNTNAP3
|
contactin associated protein-like 3 |
chr1_-_35450897 | 0.40 |
ENST00000373337.3
|
ZMYM6NB
|
ZMYM6 neighbor |
chr2_+_132479948 | 0.40 |
ENST00000355171.4
|
C2orf27A
|
chromosome 2 open reading frame 27A |
chr7_+_130126012 | 0.40 |
ENST00000341441.5
|
MEST
|
mesoderm specific transcript |
chr22_-_39268308 | 0.39 |
ENST00000407418.3
|
CBX6
|
chromobox homolog 6 |
chr10_-_14596140 | 0.38 |
ENST00000496330.1
|
FAM107B
|
family with sequence similarity 107, member B |
chr16_+_28763108 | 0.38 |
ENST00000357796.3
ENST00000550983.1 |
NPIPB9
|
nuclear pore complex interacting protein family, member B9 |
chr7_-_139763521 | 0.38 |
ENST00000263549.3
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr2_+_11696464 | 0.38 |
ENST00000234142.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
chr17_+_6918354 | 0.38 |
ENST00000552775.1
|
C17orf49
|
chromosome 17 open reading frame 49 |
chr16_+_53412368 | 0.37 |
ENST00000565189.1
|
RP11-44F14.2
|
RP11-44F14.2 |
chr10_+_90660832 | 0.37 |
ENST00000371924.1
|
STAMBPL1
|
STAM binding protein-like 1 |
chr17_-_7760457 | 0.37 |
ENST00000576384.1
|
LSMD1
|
LSM domain containing 1 |
chr14_+_37641012 | 0.37 |
ENST00000556667.1
|
SLC25A21-AS1
|
SLC25A21 antisense RNA 1 |
chr7_+_13141010 | 0.37 |
ENST00000443947.1
|
AC011288.2
|
AC011288.2 |
chr4_-_120243545 | 0.37 |
ENST00000274024.3
|
FABP2
|
fatty acid binding protein 2, intestinal |
chr14_+_20187174 | 0.36 |
ENST00000557414.1
|
OR4N2
|
olfactory receptor, family 4, subfamily N, member 2 |
chr6_-_76072719 | 0.36 |
ENST00000370020.1
|
FILIP1
|
filamin A interacting protein 1 |
chr16_+_28565230 | 0.36 |
ENST00000317058.3
|
CCDC101
|
coiled-coil domain containing 101 |
chr13_+_78315348 | 0.35 |
ENST00000441784.1
|
SLAIN1
|
SLAIN motif family, member 1 |
chr17_+_18647326 | 0.35 |
ENST00000395667.1
ENST00000395665.4 ENST00000308799.4 ENST00000301938.4 |
FBXW10
|
F-box and WD repeat domain containing 10 |
chr22_+_39966758 | 0.35 |
ENST00000407673.1
ENST00000401624.1 ENST00000404898.1 ENST00000402142.3 ENST00000336649.4 ENST00000400164.3 |
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit |
chr12_-_91573132 | 0.35 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr4_-_159956333 | 0.35 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
chr9_-_28670283 | 0.34 |
ENST00000379992.2
|
LINGO2
|
leucine rich repeat and Ig domain containing 2 |
chr8_-_110986918 | 0.34 |
ENST00000297404.1
|
KCNV1
|
potassium channel, subfamily V, member 1 |
chr15_-_56757329 | 0.34 |
ENST00000260453.3
|
MNS1
|
meiosis-specific nuclear structural 1 |
chr2_-_228582709 | 0.34 |
ENST00000541617.1
ENST00000409456.2 ENST00000409287.1 ENST00000258403.3 |
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3 |
chr7_+_130126165 | 0.34 |
ENST00000427521.1
ENST00000416162.2 ENST00000378576.4 |
MEST
|
mesoderm specific transcript |
chr16_+_12059091 | 0.34 |
ENST00000562385.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr5_+_140201183 | 0.34 |
ENST00000529619.1
ENST00000529859.1 ENST00000378126.3 |
PCDHA5
|
protocadherin alpha 5 |
chr1_+_221051699 | 0.33 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
chr12_-_10588539 | 0.33 |
ENST00000381902.2
ENST00000381901.1 ENST00000539033.1 |
KLRC2
NKG2-E
|
killer cell lectin-like receptor subfamily C, member 2 Uncharacterized protein |
chr1_-_242612779 | 0.33 |
ENST00000427495.1
|
PLD5
|
phospholipase D family, member 5 |
chr6_+_30029008 | 0.33 |
ENST00000332435.5
ENST00000376782.2 ENST00000359374.4 ENST00000376785.2 |
ZNRD1
|
zinc ribbon domain containing 1 |
chr17_+_8191815 | 0.33 |
ENST00000226105.6
ENST00000407006.4 ENST00000580434.1 ENST00000439238.3 |
RANGRF
|
RAN guanine nucleotide release factor |
chr2_+_149974684 | 0.33 |
ENST00000450639.1
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
chr17_-_8263538 | 0.33 |
ENST00000535173.1
|
AC135178.1
|
HCG1985372; Uncharacterized protein; cDNA FLJ37541 fis, clone BRCAN2026340 |
chrX_-_100662881 | 0.32 |
ENST00000218516.3
|
GLA
|
galactosidase, alpha |
chr2_-_179343268 | 0.32 |
ENST00000424785.2
|
FKBP7
|
FK506 binding protein 7 |
chr2_-_27712583 | 0.32 |
ENST00000260570.3
ENST00000359466.6 ENST00000416524.2 |
IFT172
|
intraflagellar transport 172 homolog (Chlamydomonas) |
chr11_+_17281900 | 0.32 |
ENST00000530527.1
|
NUCB2
|
nucleobindin 2 |
chr2_-_145277569 | 0.32 |
ENST00000303660.4
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr13_-_88323218 | 0.32 |
ENST00000436290.2
ENST00000453832.2 ENST00000606590.1 |
MIR4500HG
|
MIR4500 host gene (non-protein coding) |
chr16_+_14802801 | 0.32 |
ENST00000526520.1
ENST00000531598.2 |
NPIPA3
|
nuclear pore complex interacting protein family, member A3 |
chr5_-_20575959 | 0.32 |
ENST00000507958.1
|
CDH18
|
cadherin 18, type 2 |
chrX_-_15332665 | 0.32 |
ENST00000537676.1
ENST00000344384.4 |
ASB11
|
ankyrin repeat and SOCS box containing 11 |
chr15_-_64386120 | 0.32 |
ENST00000300030.3
|
FAM96A
|
family with sequence similarity 96, member A |
chr5_+_140227048 | 0.32 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
chr16_-_29415350 | 0.31 |
ENST00000524087.1
|
NPIPB11
|
nuclear pore complex interacting protein family, member B11 |
chr1_-_242612726 | 0.31 |
ENST00000459864.1
|
PLD5
|
phospholipase D family, member 5 |
chr15_+_78857849 | 0.31 |
ENST00000299565.5
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
chr14_-_30766223 | 0.30 |
ENST00000549360.1
ENST00000508469.2 |
CTD-2251F13.1
|
CTD-2251F13.1 |
chr10_-_112678904 | 0.30 |
ENST00000423273.1
ENST00000436562.1 ENST00000447005.1 ENST00000454061.1 |
BBIP1
|
BBSome interacting protein 1 |
chr17_-_4938712 | 0.30 |
ENST00000254853.5
ENST00000424747.1 |
SLC52A1
|
solute carrier family 52 (riboflavin transporter), member 1 |
chr20_-_55934878 | 0.30 |
ENST00000543500.1
|
MTRNR2L3
|
MT-RNR2-like 3 |
chr16_-_28374829 | 0.30 |
ENST00000532254.1
|
NPIPB6
|
nuclear pore complex interacting protein family, member B6 |
chr6_-_49712123 | 0.30 |
ENST00000263045.4
|
CRISP3
|
cysteine-rich secretory protein 3 |
chr21_+_33671160 | 0.30 |
ENST00000303645.5
|
MRAP
|
melanocortin 2 receptor accessory protein |
chr16_-_21868978 | 0.29 |
ENST00000357370.5
ENST00000451409.1 ENST00000341400.7 ENST00000518761.4 |
NPIPB4
|
nuclear pore complex interacting protein family, member B4 |
chr11_-_18548426 | 0.29 |
ENST00000357193.3
ENST00000536719.1 |
TSG101
|
tumor susceptibility 101 |
chr16_+_11439286 | 0.29 |
ENST00000312499.5
ENST00000576027.1 |
RMI2
|
RecQ mediated genome instability 2 |
chr11_+_7618413 | 0.29 |
ENST00000528883.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr5_+_140254884 | 0.29 |
ENST00000398631.2
|
PCDHA12
|
protocadherin alpha 12 |
chr11_-_74800799 | 0.29 |
ENST00000305159.3
|
OR2AT4
|
olfactory receptor, family 2, subfamily AT, member 4 |
chr3_-_191000172 | 0.29 |
ENST00000427544.2
|
UTS2B
|
urotensin 2B |
chr19_+_36027660 | 0.29 |
ENST00000585510.1
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
chr12_+_58176525 | 0.28 |
ENST00000543727.1
ENST00000540550.1 ENST00000323833.8 ENST00000350762.5 ENST00000550559.1 ENST00000548851.1 ENST00000434359.1 ENST00000457189.1 |
TSFM
|
Ts translation elongation factor, mitochondrial |
chr3_-_186262166 | 0.28 |
ENST00000307944.5
|
CRYGS
|
crystallin, gamma S |
chr4_-_110723194 | 0.28 |
ENST00000394635.3
|
CFI
|
complement factor I |
chr15_-_80263506 | 0.27 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr12_-_10573149 | 0.27 |
ENST00000381904.2
ENST00000381903.2 ENST00000396439.2 |
KLRC3
|
killer cell lectin-like receptor subfamily C, member 3 |
chr15_-_64385981 | 0.27 |
ENST00000557835.1
ENST00000380290.3 ENST00000559950.1 |
FAM96A
|
family with sequence similarity 96, member A |
chr4_-_130692631 | 0.26 |
ENST00000500092.2
ENST00000509105.1 |
RP11-519M16.1
|
RP11-519M16.1 |
chr7_-_87342564 | 0.26 |
ENST00000265724.3
ENST00000416177.1 |
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
chr16_+_72142195 | 0.26 |
ENST00000563819.1
ENST00000567142.2 |
DHX38
|
DEAH (Asp-Glu-Ala-His) box polypeptide 38 |
chr3_+_138340049 | 0.26 |
ENST00000464668.1
|
FAIM
|
Fas apoptotic inhibitory molecule |
chr1_+_215179188 | 0.26 |
ENST00000391895.2
|
KCNK2
|
potassium channel, subfamily K, member 2 |
chrX_+_150565653 | 0.26 |
ENST00000330374.6
|
VMA21
|
VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) |
chr1_-_106161540 | 0.26 |
ENST00000420901.1
ENST00000610126.1 ENST00000435253.2 |
RP11-251P6.1
|
RP11-251P6.1 |
chr2_+_135596106 | 0.26 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr5_+_54455946 | 0.26 |
ENST00000503787.1
ENST00000296734.6 ENST00000515370.1 |
GPX8
|
glutathione peroxidase 8 (putative) |
chr3_-_87325612 | 0.25 |
ENST00000561167.1
ENST00000560656.1 ENST00000344265.3 |
POU1F1
|
POU class 1 homeobox 1 |
chr6_-_116833500 | 0.25 |
ENST00000356128.4
|
TRAPPC3L
|
trafficking protein particle complex 3-like |
chr6_+_27925019 | 0.25 |
ENST00000244623.1
|
OR2B6
|
olfactory receptor, family 2, subfamily B, member 6 |
chr7_-_111032971 | 0.25 |
ENST00000450877.1
|
IMMP2L
|
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
chr4_+_139694701 | 0.25 |
ENST00000502606.1
|
RP11-98O2.1
|
RP11-98O2.1 |
chr7_+_11013491 | 0.25 |
ENST00000403050.3
ENST00000445996.2 |
PHF14
|
PHD finger protein 14 |
chr16_+_28648975 | 0.25 |
ENST00000529716.1
|
NPIPB8
|
nuclear pore complex interacting protein family, member B8 |
chr15_+_71389281 | 0.25 |
ENST00000355327.3
|
THSD4
|
thrombospondin, type I, domain containing 4 |
chr2_+_241499719 | 0.25 |
ENST00000405954.1
|
DUSP28
|
dual specificity phosphatase 28 |
chr4_+_80584903 | 0.24 |
ENST00000506460.1
|
RP11-452C8.1
|
RP11-452C8.1 |
chr12_-_10022735 | 0.24 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr8_-_90769422 | 0.24 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
chr4_+_71108300 | 0.24 |
ENST00000304954.3
|
CSN3
|
casein kappa |
chr6_-_24645956 | 0.24 |
ENST00000543707.1
|
KIAA0319
|
KIAA0319 |
chr13_+_78315466 | 0.24 |
ENST00000314070.5
ENST00000462234.1 |
SLAIN1
|
SLAIN motif family, member 1 |
chr3_+_138340067 | 0.24 |
ENST00000479848.1
|
FAIM
|
Fas apoptotic inhibitory molecule |
chr10_-_112678976 | 0.24 |
ENST00000448814.1
|
BBIP1
|
BBSome interacting protein 1 |
chr7_-_99716952 | 0.24 |
ENST00000523306.1
ENST00000344095.4 ENST00000417349.1 ENST00000493322.1 ENST00000520135.1 ENST00000418432.2 ENST00000460673.2 ENST00000452041.1 ENST00000452438.2 ENST00000451699.1 ENST00000453269.2 |
TAF6
|
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa |
chrX_-_122756660 | 0.23 |
ENST00000441692.1
|
THOC2
|
THO complex 2 |
chr11_+_327171 | 0.23 |
ENST00000534483.1
ENST00000524824.1 ENST00000531076.1 |
RP11-326C3.12
|
RP11-326C3.12 |
chr6_-_52859046 | 0.23 |
ENST00000457564.1
ENST00000541324.1 ENST00000370960.1 |
GSTA4
|
glutathione S-transferase alpha 4 |
chr18_+_61616510 | 0.23 |
ENST00000408945.3
|
HMSD
|
histocompatibility (minor) serpin domain containing |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
0.5 | 1.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.5 | 1.4 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.4 | 1.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.4 | 1.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.3 | 1.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.2 | 1.2 | GO:0071893 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.2 | 1.2 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 2.2 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 1.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 2.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 1.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 4.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.4 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 0.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 3.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.3 | GO:2000397 | positive regulation of viral budding via host ESCRT complex(GO:1903774) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.6 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.3 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.2 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 0.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 1.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.1 | 0.4 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.1 | 0.2 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.2 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.1 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 0.5 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.0 | 0.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.2 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.0 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.1 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.0 | 0.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.0 | 0.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 1.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.3 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.3 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.5 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.3 | GO:0016139 | glycoside catabolic process(GO:0016139) glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.0 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.0 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.1 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 1.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.0 | 0.4 | GO:0008037 | cell recognition(GO:0008037) |
0.0 | 0.1 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.0 | 0.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.1 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.8 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.0 | 1.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 1.3 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 0.8 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0035566 | regulation of metanephros size(GO:0035566) |
0.0 | 0.0 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.0 | 0.0 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.0 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 1.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.2 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 3.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.4 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.0 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.1 | GO:0032127 | dense core granule membrane(GO:0032127) microvesicle(GO:1990742) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.0 | 0.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 2.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 2.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0047017 | geranylgeranyl reductase activity(GO:0045550) prostaglandin-F synthase activity(GO:0047017) |
0.4 | 1.1 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.3 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 2.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.6 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.2 | 0.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 4.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.3 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.2 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.4 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) copper-dependent protein binding(GO:0032767) |
0.1 | 3.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.0 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.0 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 1.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.0 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.4 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 1.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.0 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 1.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 2.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 1.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 1.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 1.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |